Thoracic Surgery Unit, Second University of Naples, Naples, Italy.
Eur J Cardiothorac Surg. 2011 Jul;40(1):136-42. doi: 10.1016/j.ejcts.2010.10.005. Epub 2011 Jan 26.
To evaluate the usefulness of (99m)Tc-2-Methoxy-Isobutyl-Isonitrile Single Photon Emission Computed Tomography (MIBI-SPECT) for assessing anterior mediastinal mass, and distinguishing the grade of malignancy of thymic epithelial tumors to offer guidance for decision making.
From January 2006 to November 2009, 31 consecutive patients with an anterior mediastinal mass at CT were enrolled. All patients underwent (99m)Tc-MIBI-SPECT before invasive diagnostic procedures and/or surgical resection. The uptake of the mediastinal tumor (T) was compared with the normal tissue (N) and the T/N ratio was calculated to define the metabolic activity of the lesions. Patients were divided into six groups according histologic patterns, which were then correlated to the T/N value: benign tumor (BT), lymphoma (LYM), other malignant tumor (OMT), and low-risk thymoma (LRT) including types A, AB, and B1, high-risk thymoma (HRT) including types B2 and B3, and thymic carcinoma (TC).
There were five BT, eight LRT (four = A, two = AB, and two = B1), four HRT (three = B2 and one = B3), four thymic carcinoma, six LYM and four OMT. The T/N value of BT, LRT, HRT, CT, LYM, and OMT was 1.3 ± 0.3, 1.3 ± 0.2, 1.8 ± 0.3, 2.7 ± 0.5, 2.8 ± 0.1, and 2.9 ± 0.2, respectively. The T/N ratio of BT and of LRT was significantly lower than that of HRT, of CT, of LYM, and of OMT (p < 0.05), while there is no significant difference of MIBI uptake between BT and LRT. MIBI uptake in HRT was significantly lower than that in TC, LYM, and OMT (p < 0.05), whereas no significant difference was found between the different types of malignant lesions (TC, LYM, and OMT). Regarding thymoma, the degree of MIBI accumulation significantly increased as the World Health Organization (WHO) classification shifted from type A to type B and to TC. Yet, the T/N value of stages I and II was significantly lower than that of stages III and IV. The size of the lesion and the presence of myasthenia were not correlated with MIBI uptake.
(99m)Tc-MIBI-SPECT seems to be useful in the evaluation of malignancy in anterior mediastinal mass, and is significantly correlated with the WHO classification and the Masaoka stage. Thus, this technique may add further information to morphological studies for decision making.
评估(99m)Tc-2-甲氧基异丁基异腈单光子发射计算机断层扫描(MIBI-SPECT)在评估前纵隔肿块以及区分胸腺癌的恶性程度方面的作用,为决策提供指导。
2006 年 1 月至 2009 年 11 月,对 31 例 CT 检查发现前纵隔肿块的连续患者进行了研究。所有患者在进行有创诊断程序和/或手术切除前均进行了(99m)Tc-MIBI-SPECT 检查。将纵隔肿瘤(T)的摄取与正常组织(N)进行比较,并计算 T/N 比值以定义病变的代谢活性。根据组织学模式将患者分为六组,然后将其与 T/N 值相关联:良性肿瘤(BT)、淋巴瘤(LYM)、其他恶性肿瘤(OMT)和低危胸腺瘤(LRT),包括 A、AB 和 B1 型,高危胸腺瘤(HRT),包括 B2 和 B3 型,以及胸腺癌(TC)。
有 5 例 BT、8 例 LRT(4 例=A、2 例=AB、2 例=B1)、4 例 HRT(3 例=B2、1 例=B3)、4 例胸腺癌、6 例 LYM 和 4 例 OMT。BT、LRT、HRT、CT、LYM 和 OMT 的 T/N 值分别为 1.3±0.3、1.3±0.2、1.8±0.3、2.7±0.5、2.8±0.1 和 2.9±0.2。BT 和 LRT 的 T/N 比值明显低于 HRT、CT、LYM 和 OMT(p<0.05),而 BT 和 LRT 的 MIBI 摄取无显著差异。HRT 的 MIBI 摄取明显低于 TC、LYM 和 OMT(p<0.05),而恶性病变(TC、LYM 和 OMT)之间的摄取无显著差异。关于胸腺瘤,随着世界卫生组织(WHO)分类从 A 型到 B 型和 TC 型的转变,MIBI 堆积的程度显著增加。然而,I 期和 II 期的 T/N 值明显低于 III 期和 IV 期。病变的大小和重症肌无力的存在与 MIBI 摄取无关。
(99m)Tc-MIBI-SPECT 似乎可用于评估前纵隔肿块的恶性程度,与 WHO 分类和 Masaoka 分期显著相关。因此,该技术可为决策提供形态学研究的补充信息。